Terlipressin and albumin in patients with cirrhosis and type I hepatorenal syndrome

Digestive Diseases and Sciences

Volumn 53, Issue 3, 2008, Pages 830-835

  Neri, Sergio ^a   Pulvirenti, Davide ^a   Malaguarnera, Mariano ^a   Cosimo, Bruno M ^a   Bertino, Gaetano ^a   Ignaccolo, Luca ^a   Siringo, Sebasiano ^b   Castellino, Pietro ^a  

^a UNIVERSITY OF CATANIA   (Italy)

^b GARIBALDI HOSPITAL   (Italy)

Author keywords

Albumin; Ascites; Diuretics; Hepatorenal syndrome; Liver cirrhosis; Terlipressin

Indexed keywords

ALBUMIN; ALDOSTERONE; CREATININE; RENIN; TERLIPRESSIN;

ABDOMINAL PAIN; ADULT; ALBUMIN BLOOD LEVEL; ALDOSTERONE BLOOD LEVEL; ARTICLE; BLEEDING; BOLUS INJECTION; BRAIN HEMORRHAGE; CAUSE OF DEATH; CENTRAL VENOUS PRESSURE; CLINICAL TRIAL; COHORT ANALYSIS; COMBINATION CHEMOTHERAPY; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CREATININE BLOOD LEVEL; DRUG SAFETY; DRUG WITHDRAWAL; FEMALE; HEMODYNAMICS; HEPATORENAL SYNDROME; HUMAN; INTESTINE ISCHEMIA; KIDNEY FUNCTION; LIVER CIRRHOSIS; LIVER FAILURE; LIVER FUNCTION; MAJOR CLINICAL STUDY; MALE; MEAN ARTERIAL PRESSURE; MONOTHERAPY; MULTIPLE ORGAN FAILURE; PATIENT MONITORING; PLASMA RENIN ACTIVITY; PRIORITY JOURNAL; PROBABILITY; PROTEIN BLOOD LEVEL; STATISTICAL SIGNIFICANCE; SURVIVAL; TREATMENT OUTCOME; TREATMENT RESPONSE; URINE VOLUME;

ALBUMINS; FEMALE; HEPATORENAL SYNDROME; HUMANS; KIDNEY FUNCTION TESTS; LIVER CIRRHOSIS; LYSINE VASOPRESSIN; MALE; MIDDLE AGED; TIME FACTORS; VASOCONSTRICTOR AGENTS;

EID: 39849106473     PISSN: 01632116     EISSN: None     Source Type: Journal    
DOI: 10.1007/s10620-007-9919-9     Document Type: Article

References (15)

1. Arroyo V, Ginès P, Gerbes AL, Dudley FJ, Gentilini P, Laffi G, Reynolds TB, Ring-Larsen H, Scholmerich J (1996) Definition and diagnostic criteria of refractory ascites and hepatorenal syndrome in cirrhosis. Hepatology 23:164-176
2. Angeli P (2004) Prognosis of hepatorenal syndrome-has it changed with current practice? Aliment Pharmacol Ther 20(3):44-46
3. Barada K (2004) Hepatorenal syndrome: pathogenesis and novel pharmacological targets. Curr Opin Pharmacol 4:189-197
4. Guevara M, Rodés J (2005) Hepatorenal syndrome. Int J Biochem Cell Biol 37:22-26
5. Ginès P, Guevara N, Perez-Villa F (2004) Management of hepatorenal syndrome: another piece of the puzzle. Hepatology 40:16-18
6. Gardenas A (2005) Hepatorenal syndrome: a dreaded complication of end-stage liver disease. Am J Gastroenterol 100:460-467
7. Gines P, Guevara M, Arroyo V, Rodes J (2003) Hepatorenal syndrome. Lancet 362:1819-1827
8. Therapondos G, Stanley AJ, Hayes PC (2004) Systemic, portal and renal effects of terlipressin in patients with cirrhotic ascites: pilot study. J Gastroenterol Hepatol 19:73-77
9. Antoniades C, Auzinger G (2003) Terlipressin and albumin for the hepatorenal syndrome. Hepatology 37:946
10. Colle I, Durand F, Pessione F, Rassiat E, Bernuau J, Barriere E, Lebrec D, Valla DC, Moreau R (2002) Clinical course, predictive factors and prognosis in patients with cirrhosis and type 1 hepatorenal syndrome treated with terlipressin: a retrospective analysis. J Gastroenterol Hepatol 17:882-888
11. Ortega R, Gines P, Uriz J, Cardenas A, Calahorra B, De Las Heras D, Guevara M, Bataller R, Jimenez W, Arroyo W, Rodes J (2002) Terlipressin therapy with and without albumin for patients with hepatorenal syndrome: results of a prospective, nonrandomized study. Hepatology 36:941-948
12. Solanki P, Chawla A, Garg R, Gupta R, Jain M, Sarin SK (2003) Beneficial effects of terlipressin in hepatorenal syndrome: a prospective, randomized placebo-controlled clinical trial. J Gastroenterol Hepatol 18:152-156
13. Uriz J, Gines P, Cardenas A, Sort P, Jimenez W, Salmeron JM, Bataller R, Mas A, Navasa M, Arroyo V, Rodes J (2000) Terlipressin plus albumin infusion: an effective and safe therapy of hepatorenal syndrome. J Hepatol 33:43-48
14. Duvoux C, Zanditenas D, Hezode C, Chauvat A, Monin JL,Roudot-Thoraval F, Mallat A, Dhumeaux D (2002) Effects of noradrenalin and albumin in patients with type I hepatorenal syndrome: a pilot study. Hepatology 362:374-380
15. Moreau R, Assellah T, Condat B, de Kerguenec C, Pessione F, Bernard B, Poynard T, Binn M, Grange JD, Valla D, Lebrec D (2002) Comparison of the effects of terlipressin and albumin on arterial blood volume in patients with cirrhosis and tense ascites treated by paracentesis: a randomized pilot study. Gut 50:90-94